ID

35820

Description

Famine From Feast: Linking Vitamin C, Red Blood Cell Fragility, and Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT02107976

Link

https://clinicaltrials.gov/show/NCT02107976

Keywords

Versions (1)
  1. 3/25/19 3/25/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

March 25, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diabetes Type 2 NCT02107976

English

Eligibility Diabetes Type 2 NCT02107976

1 forms  
Criteria
Description

Criteria

male or female 18-60 years old, able to give informed consent.
Description

Age | Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0021430
diabetes type 2 hga1c 7-12 percent on insulin and/or oral hypoglycemic agents.
Description

Diabetes Mellitus, Non-Insulin-Dependent | Hemoglobin A1c measurement | Insulin | Hypoglycemic Agents Oral

Data type

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0474680
UMLS CUI [3]
C0021641
UMLS CUI [4,1]
C0020616
UMLS CUI [4,2]
C1527415
in general good health with no other significant illness.
Description

General health good | Illness Other Absent

Data type

boolean

Alias
UMLS CUI [1]
C1277245
UMLS CUI [2,1]
C0221423
UMLS CUI [2,2]
C0205394
UMLS CUI [2,3]
C0332197
mild concomitant disease such as mild hypothyroidism (tsh < 10) is acceptable.
Description

Comorbidity Mild Acceptable | Hypothyroidism Mild | Thyroid stimulating hormone measurement

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C2945599
UMLS CUI [1,3]
C1879533
UMLS CUI [2,1]
C0020676
UMLS CUI [2,2]
C2945599
UMLS CUI [3]
C0202230
blood pressure with or without medication < 160/90 mmhg with no known significant target organ damage (end organ damage includes the following: proliferative retinopathy, serum creatinine > 1.5 or egfr < 55 ml/min, symptomatic ischemic heart disease, severe congestive heart failure, advanced peripheral vascular disease.
Description

Blood pressure determination | Relationship Pharmaceutical Preparations | Independent of Pharmaceutical Preparations | Target Organ Damage Absent | Proliferative retinopathy | Creatinine measurement, serum | Estimated Glomerular Filtration Rate | Myocardial Ischemia Symptomatic | Congestive heart failure Severe | Peripheral Vascular Disease Advanced

Data type

boolean

Alias
UMLS CUI [1]
C0005824
UMLS CUI [2,1]
C0439849
UMLS CUI [2,2]
C0013227
UMLS CUI [3,1]
C0332291
UMLS CUI [3,2]
C0013227
UMLS CUI [4,1]
C1521840
UMLS CUI [4,2]
C0178784
UMLS CUI [4,3]
C1883709
UMLS CUI [4,4]
C0332197
UMLS CUI [5]
C0339467
UMLS CUI [6]
C0201976
UMLS CUI [7]
C3811844
UMLS CUI [8,1]
C0151744
UMLS CUI [8,2]
C0231220
UMLS CUI [9,1]
C0018802
UMLS CUI [9,2]
C0205082
UMLS CUI [10,1]
C0085096
UMLS CUI [10,2]
C0205179
plasma/rbc vitamin c levels less than or equal to 30 microm.
Description

Plasma Vitamin C level | Erythrocytes Vitamin C level

Data type

boolean

Alias
UMLS CUI [1,1]
C0032105
UMLS CUI [1,2]
C0201898
UMLS CUI [2,1]
C0014792
UMLS CUI [2,2]
C0201898
willingness to use effective contraceptive methods such as barrier method for the duration of study (female subjects).
Description

Gender Contraceptive methods | Contraception, Barrier

Data type

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0700589
UMLS CUI [2]
C0004764
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
diabetic type 1 subjects will be excluded due to the possibility of ketosis and hemodynamic instability with lack of insulin.
Description

Diabetes Mellitus, Insulin-Dependent | At risk Ketosis | At risk Hemodynamic instability

Data type

boolean

Alias
UMLS CUI [1]
C0011854
UMLS CUI [2,1]
C1444641
UMLS CUI [2,2]
C0022638
UMLS CUI [3,1]
C1444641
UMLS CUI [3,2]
C0948268
any subjective or objective evidence of microangiopathy such as history of claudication, symptomatic peripheral vascular disease, symptomatic coronary artery disease, stroke, retinopathy, nephropathy (serum creatinine > 1.5 or egfr < 55 ml/min).
Description

Microangiopathy | Claudication | Peripheral Vascular Diseases Symptomatic | Coronary Artery Disease Symptomatic | Cerebrovascular accident | Retinal Diseases | Kidney Diseases | Creatinine measurement, serum | Estimated Glomerular Filtration Rate

Data type

boolean

Alias
UMLS CUI [1]
C0155765
UMLS CUI [2]
C1456822
UMLS CUI [3,1]
C0085096
UMLS CUI [3,2]
C0231220
UMLS CUI [4,1]
C1956346
UMLS CUI [4,2]
C0231220
UMLS CUI [5]
C0038454
UMLS CUI [6]
C0035309
UMLS CUI [7]
C0022658
UMLS CUI [8]
C0201976
UMLS CUI [9]
C3811844
subjects with retinopathy to avoid accelerated retinopathy with hyperglycemia.
Description

Retinal Disease

Data type

boolean

Alias
UMLS CUI [1]
C0035309
concomitant disease such as severe heart failure, severe liver disease (transaminases > 3 times normal), or severe systemic disease of any sort.
Description

Comorbidity | Heart failure Severe | Liver disease Severe | Transaminases increased | Systemic disease Severe

Data type

boolean

Alias
UMLS CUI [1]
C0009488
UMLS CUI [2,1]
C0018801
UMLS CUI [2,2]
C0205082
UMLS CUI [3,1]
C0023895
UMLS CUI [3,2]
C0205082
UMLS CUI [4]
C0438717
UMLS CUI [5,1]
C0442893
UMLS CUI [5,2]
C0205082
participation in each protocol delineated evaluation procedure will be judged on a case by case basis with patient safety as the paramount consideration.
Description

Study Subject Participation Status | Consideration Patient safety

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C0518609
UMLS CUI [2,2]
C1113679
pregnancy, breastfeeding.
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
history of diabetic ketoacidosis or hyperosmolar coma.
Description

Diabetic Ketoacidosis | Hyperosmolar Coma

Data type

boolean

Alias
UMLS CUI [1]
C0011880
UMLS CUI [2]
C0020457
Back to the top of the page

Similar models

Eligibility Diabetes Type 2 NCT02107976

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Age | Informed Consent
Item
male or female 18-60 years old, able to give informed consent.
boolean
C0001779 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
Diabetes Mellitus, Non-Insulin-Dependent | Hemoglobin A1c measurement | Insulin | Hypoglycemic Agents Oral
Item
diabetes type 2 hga1c 7-12 percent on insulin and/or oral hypoglycemic agents.
boolean
C0011860 (UMLS CUI [1])
C0474680 (UMLS CUI [2])
C0021641 (UMLS CUI [3])
C0020616 (UMLS CUI [4,1])
C1527415 (UMLS CUI [4,2])
General health good | Illness Other Absent
Item
in general good health with no other significant illness.
boolean
C1277245 (UMLS CUI [1])
C0221423 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
Comorbidity Mild Acceptable | Hypothyroidism Mild | Thyroid stimulating hormone measurement
Item
mild concomitant disease such as mild hypothyroidism (tsh < 10) is acceptable.
boolean
C0009488 (UMLS CUI [1,1])
C2945599 (UMLS CUI [1,2])
C1879533 (UMLS CUI [1,3])
C0020676 (UMLS CUI [2,1])
C2945599 (UMLS CUI [2,2])
C0202230 (UMLS CUI [3])
Blood pressure determination | Relationship Pharmaceutical Preparations | Independent of Pharmaceutical Preparations | Target Organ Damage Absent | Proliferative retinopathy | Creatinine measurement, serum | Estimated Glomerular Filtration Rate | Myocardial Ischemia Symptomatic | Congestive heart failure Severe | Peripheral Vascular Disease Advanced
Item
blood pressure with or without medication < 160/90 mmhg with no known significant target organ damage (end organ damage includes the following: proliferative retinopathy, serum creatinine > 1.5 or egfr < 55 ml/min, symptomatic ischemic heart disease, severe congestive heart failure, advanced peripheral vascular disease.
boolean
C0005824 (UMLS CUI [1])
C0439849 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0332291 (UMLS CUI [3,1])
C0013227 (UMLS CUI [3,2])
C1521840 (UMLS CUI [4,1])
C0178784 (UMLS CUI [4,2])
C1883709 (UMLS CUI [4,3])
C0332197 (UMLS CUI [4,4])
C0339467 (UMLS CUI [5])
C0201976 (UMLS CUI [6])
C3811844 (UMLS CUI [7])
C0151744 (UMLS CUI [8,1])
C0231220 (UMLS CUI [8,2])
C0018802 (UMLS CUI [9,1])
C0205082 (UMLS CUI [9,2])
C0085096 (UMLS CUI [10,1])
C0205179 (UMLS CUI [10,2])
Plasma Vitamin C level | Erythrocytes Vitamin C level
Item
plasma/rbc vitamin c levels less than or equal to 30 microm.
boolean
C0032105 (UMLS CUI [1,1])
C0201898 (UMLS CUI [1,2])
C0014792 (UMLS CUI [2,1])
C0201898 (UMLS CUI [2,2])
Gender Contraceptive methods | Contraception, Barrier
Item
willingness to use effective contraceptive methods such as barrier method for the duration of study (female subjects).
boolean
C0079399 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0004764 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent | At risk Ketosis | At risk Hemodynamic instability
Item
diabetic type 1 subjects will be excluded due to the possibility of ketosis and hemodynamic instability with lack of insulin.
boolean
C0011854 (UMLS CUI [1])
C1444641 (UMLS CUI [2,1])
C0022638 (UMLS CUI [2,2])
C1444641 (UMLS CUI [3,1])
C0948268 (UMLS CUI [3,2])
Microangiopathy | Claudication | Peripheral Vascular Diseases Symptomatic | Coronary Artery Disease Symptomatic | Cerebrovascular accident | Retinal Diseases | Kidney Diseases | Creatinine measurement, serum | Estimated Glomerular Filtration Rate
Item
any subjective or objective evidence of microangiopathy such as history of claudication, symptomatic peripheral vascular disease, symptomatic coronary artery disease, stroke, retinopathy, nephropathy (serum creatinine > 1.5 or egfr < 55 ml/min).
boolean
C0155765 (UMLS CUI [1])
C1456822 (UMLS CUI [2])
C0085096 (UMLS CUI [3,1])
C0231220 (UMLS CUI [3,2])
C1956346 (UMLS CUI [4,1])
C0231220 (UMLS CUI [4,2])
C0038454 (UMLS CUI [5])
C0035309 (UMLS CUI [6])
C0022658 (UMLS CUI [7])
C0201976 (UMLS CUI [8])
C3811844 (UMLS CUI [9])
Retinal Disease
Item
subjects with retinopathy to avoid accelerated retinopathy with hyperglycemia.
boolean
C0035309 (UMLS CUI [1])
Comorbidity | Heart failure Severe | Liver disease Severe | Transaminases increased | Systemic disease Severe
Item
concomitant disease such as severe heart failure, severe liver disease (transaminases > 3 times normal), or severe systemic disease of any sort.
boolean
C0009488 (UMLS CUI [1])
C0018801 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0023895 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0438717 (UMLS CUI [4])
C0442893 (UMLS CUI [5,1])
C0205082 (UMLS CUI [5,2])
Study Subject Participation Status | Consideration Patient safety
Item
participation in each protocol delineated evaluation procedure will be judged on a case by case basis with patient safety as the paramount consideration.
boolean
C2348568 (UMLS CUI [1])
C0518609 (UMLS CUI [2,1])
C1113679 (UMLS CUI [2,2])
Pregnancy | Breast Feeding
Item
pregnancy, breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Diabetic Ketoacidosis | Hyperosmolar Coma
Item
history of diabetic ketoacidosis or hyperosmolar coma.
boolean
C0011880 (UMLS CUI [1])
C0020457 (UMLS CUI [2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial